Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma

John de Groot; Albert H. Kim; Sujit S. Prabhu; Ganesh Rao; Adrian W. Laxton; Peter E. Fecci; Barbara O’Brien; Andrew E. Sloan; Veronica Chiang; Stephen B. Tatter; Alireza M. Mohammadi; Dimitris G. Placantonakis; Roy E. Strowd; Clark Chen; Costas G. Hadjipanayis; Mustafa Khasraw; David Sun; David Piccioni; Kaylyn Sinicrope; Jian Campian; Sylvia C. Kurz; Brian J. Williams; Kris A. Smith; Zulma Tovar-Spinoza; Eric C. Leuthardt

doi:10.1093/noajnl/vdac040

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Laser ablation is a viable option for patients with new and recurrent glioblastoma. Median OS for IDH wild-type newly diagnosed glioblastoma is comparable to outcomes observed in other tumor resection studies when those patients undergo radiation and chemotherapy following LITT.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Groot et al. (2022) studied this question.

synapsesocial.com/papers/69dce58c8cc25b5e451332ea https://doi.org/10.1093/noajnl/vdac040

View Full Paper

Ask AI

Bookmark

Share

Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma

Ask about this paper

Abstract

Discussion

Cite This Study

Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading